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Traumatic brain injury (TBI) in general has varied neuropathological consequences
depending upon the intensity and biomechanics of the injury. Furthermore, in
pediatric TBI, intrinsic developmental changes add further complexity, necessitating
a biochemical dimension for improved TBI characterization. In our earlier study
investigating the subacute stage TBI metabolome (72 h post-injury) in a developmental
rat model, significant ipsilateral brain biochemical changes occurred across 25
metabolite sets as determined by metabolite set enrichment analysis (MSEA). The
broad metabolic perturbation was accompanied by behavioral deficits and neuronal
loss across the ipsilateral hemisphere containing the injury epicenter. In order to obtain
a consolidated biochemical profile of the TBI assessment, a subgrouping of the 190
identified brain metabolites was performed. Metabolites were divided into seven major
subgroups: oxidative energy/mitochondrial, glycolysis/pentose phosphate pathway,
fatty acid, amino acid, neurotransmitters/neuromodulators, one-carbon/folate and other
metabolites. Subgroups were based on the chemical nature and association with
critically altered biochemical pathways after TBI as obtained from our earlier untargeted
analysis. Each metabolite subgroup extracted from the ipsilateral sham and TBI brains
were modeled using multivariate partial least square discriminant analysis (PLS-DA)
with the model accuracy used as a measurable index of TBI neurochemical impact.
Volcano plots of each subgroup, corrected for multiple comparisons, determined
the TBI neurochemical specificity. The results provide a ranked biochemical profile
along with specificity of changes after developmental TBI, enabling a consolidated
biochemical template for future classification of different TBI intensities and injury types in
animal models.
Keywords: traumatic brain injury, mitochondria, metabolomics, glycolysis, lipid metabolism, amino acid
metabolism, pediatric, citric acid cycle
INTRODUCTION
Traumatic brain injury (TBI) is a major cause of long term disability worldwide with higher
numbers of pediatric patients in the age range of 4–19 years (Faul et al., 2010; Brain Injury
Association of America, 2014). Developmental differences in TBI outcomes can be attributed to
intrinsic nature of the developing brain, presenting unique metabolism, cerebral blood flow (CBF),
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neurotransmission (Chiron et al., 1992; Biagi et al., 2007; Hales
et al., 2014), (Chugani et al., 1987), proportionally higher cell
numbers, increased central nervous system (CNS) myelination
(Dobbing and Sands, 1973), (Reiss et al., 1996; Paus et al.,
2001) and a constantly evolving neurovascular activity (Biagi
et al., 2007; Labarthe et al., 2009; Winter et al., 2011; Hales
et al., 2014), These progressive changes lead to highly variable
outcomes on the already broad TBI pathology, which depends
on injury intensity and biomechanics (Park et al., 2008; Ma
et al., 2019), making TBI classification in animal models of
injury a current challenge. Hence a biochemical dimension
to characterize preclinical TBI models may help improve TBI
classification and additionally provide mechanistic clues to the
varied pathological outcomes.
Our prior Liquid Chromatography/Mass Spectrometry (LC-
MS) based study of the TBI metabolome, characterized the
ongoing subacute stage (72 h post-TBI). TBI of a mild to
moderate intensity was induced in developing rats (age P31),
translating to human age range of 4–7 years (Chitturi et al.,
2018). A top-down untargeted metabolite set enrichment analysis
(MSEA) revealed a diverse set of affected metabolite sets in
at least 25 different biochemical pathways that broadly related
to amino acid, fatty acid, one-carbon/folate, neurotransmitter
and energy metabolism (Chitturi et al., 2018). In the current
study, a reduction (or subgrouping) of the various identified
metabolite constituents in the specific pathways affected by TBI
was performed to biochemically consolidate the injury outcome.
We hypothesized that ranking the broad biochemical pathway
changes after TBI may provide a measurable index of the relative
metabolic shifts in developmental TBI.
After lateral fluid percussion induced TBI in rats aged
P31, brains were removed at 72 h post-TBI. Extracts from
the ipsilateral hemisphere containing the injury epicenter
were analyzed using LC-MS. 190 identified metabolites were
subgrouped according to their relationship to oxidative energy
and mitochondrial metabolism, glycolysis/pentose phosphate
pathway, neurotransmitters/neuromodulator metabolism
(polyamines), fatty acid metabolism, amino acid metabolism
or one-carbon/folate metabolism, while the remaining were
categorized as other metabolites. Metabolites showing highly
significant change (determined by volcano plots), corrected
for multiple comparisons, determined the TBI neurochemical
“specificity.” A multivariate partial least square discriminant
analysis (PLS-DA) of sham versus TBI in each sub-category
was performed and the PLS-DA model accuracy defined
neurochemical “impact.”
MATERIALS AND METHODS
Animals
Male Sprague-Dawley rats (∼23-days-old; weighing 60–80 g)
were procured from Charles River Laboratories, Wilmington,
MA, United States. Animals were housed in pairs under
controlled conditions and used for the experiments at age
31 days. All procedures were approved by the Institutional
Animal Care and Use Committee of Rutgers Biomedical and
Health Sciences-New Jersey Medical School and conducted in
accordance with the National Institutes of Health guide for
the care and use of Laboratory animals (NIH Publications No.
8023, revised 1978).
Lateral Fluid-Percussion Injury
Animals (n = 16) were randomly assigned to sham and injury
groups at age P31. A lateral fluid percussion injury (FPI)
was performed in a similar manner as our previous studies
(Chitturi et al., 2018, 2019). Briefly, rats were anesthetized
with Ketamine (80 mg/kg i.p)-Xylazine (10 mg/kg i.p) and
positioned on a stereotaxic frame. After ascertaining surgical
plane anesthesia with absent tail-pinch reflexes, a 3 mm
craniotomy was performed on the left side of the skull −5 mm
posterior to the bregma and 3 mm lateral to the sagittal
suture keeping the dura intact. A Luer-Lock syringe hub was
glued surrounding the exposed dura using a cyanoacrylate
adhesive. 24 h later, injury was induced by attaching the
Luer-Lock hub to the FPI device (Virginia Commonwealth
University, Richmond, VA, United States), with the rat under
isoflurane anesthesia. A pendulum-drop delivered a brief 20 ms
impact on the intact dura. The impact pressure was measured
by an extra-cranial transducer and controlled between 1.8
and 2.0 atm. TBI group underwent the FPI procedure while
sham animals were isoflurane-anesthetized and attached to
the FPI device without the pendulum drop. Sham group
(n = 6) and TBI group (n = 9) were further considered for
the studies as mortality occurred in one TBI animal within
30 min after the FPI procedure. Animals were monitored
within their cage environment daily throughout the duration of
the experiments.
Tissue Sample Preparation, Extraction
and Liquid Chromatography/Mass
Spectrometry (LC/MS)
Animals were decapitated and brains rapidly removed (<60 s).
Cerebellum and brain stem were removed, and the cerebral
hemispheres longitudinally separated. Each hemisphere was snap
frozen in liquid nitrogen and stored in −80◦C. Brain tissue
samples were weighed and disrupted in extraction buffer (80%
methanol in water) using a micro-homogenizer. Each sample
was transferred to a pre-cooled (dry ice) homogenization tube
and 4 ml of pre-cooled 80% methanol was added to each sample
and homogenization was performed for 15 s using the standard
micro homogenizer (Pro Scientific). 500 µL of sample was taken
out to a new Eppendorf tube centrifuged at 4◦C for 15 min
at 14,000 rpm. Supernatants were collected and normalized
to tissue weight.
Targeted LC/MS analyses were performed on the brain
extract samples using a Q Exactive Orbitrap Hybrid Mass
Spectrometer (Thermo Scientific) coupled to a Vanquish UPLC
system (Thermo Scientific). The Q Exactive operated in
a polarity-switching mode. A SeQuant ZIC-HILIC column;
2.1 × 150 mmi.d, (Merck. Co., Kenilworth, NJ, United States),
was used for metabolite separation. Buffers consisted of
HPLC buffer A (100% acetonitrile), and HPLC buffer B
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(pH = 9.0: 95% (vol/vol) water, 5% (vol/vol) acetonitrile, 20 mM
ammonium hydroxide, 20 mM ammonium acetate). HPLC flow
rate was set at 150 µL/min and gradients were from 85 to 30%
for buffer A in 20 min followed by a wash with 30% buffer A and
re-equilibration at 85% buffer A. Metabolites were identified by
exact mass within 5 ppm and standard retention times. Relative
metabolite quantification was performed based on peak area for
each identified metabolite (Goncalves et al., 2018). The reliable
high-resolution accurate mass determining capability of the Q
Exactive LC-MS eliminated the need for technical replicates on
biological samples.
Data Analysis and Statistics
To minimize variations introduced during sample preparation
effects of ion suppression, metabolite peak intensities were
normalized to tissue-wet weight. Due to deviations from
normality as tested by Shapiro-Wilk’s test, data were subsequently
log transformed and auto-scaled (mean-centered and divided by
the standard deviation of each variable) effectively converting
them to Z-scores. These preprocessing steps mitigated any
experimental/sample analysis variability in the metabolite peaks.
Volcano plots were used to compare the size of the fold change
to statistical significance. Volcano plots of significantly changing
metabolites were determined using a two-sample Student’s t-test
with a probability threshold of P < 0.05 corrected for multiple
comparisons using the false discovery rate (FDR) for type-
1 error control.
Pathway-based subgroups were identified based on the
metabolite relationship to critical biochemical networks
implicated in TBI such as oxidative energy metabolism,
glycolysis/pentose phosphate pathway, neurotransmitters
and neuromodulators (polyamines), fatty acid metabolism,
amino acid metabolism, and one-carbon/Folate metabolism.
Multivariate analysis considering several dependent variables
was performed using the software Metaboanalyst 3.01, (Xia et al.,
2015). PLS-DA was used to determine the separation between
groups of the metabolite variables through rotation of the
principal components obtained by PCA. PLS-DA was used due
to the presence of more metabolite variables than observations
in addition to correlation among the variables in the data
(Tang et al., 2014). PLS-DA analysis also was used for feature
selection to generate feature importance measures (VIP: Variable
Importance in Projection). R2X and R2Y, the fraction of variation
that the model explains in the independent variables (X) and
dependent variables (Y) and the predictive accuracy of the model
(Q2Y), were estimated by the PLS-DA cross validation. Loading
plots (top 25 variables) were used to determine the clustering of
variables and testing their relationship within (weightings) for
score changes in response to TBI.
RESULTS
In a top-down metabolic exploratory analysis as reported in
our earlier studies (Chitturi et al., 2018), largest metabolite
1http://www.metaboanalyst.ca
shifts were observed between sham and TBI in the ipsilateral
hemisphere, where about 33% of the identified metabolites
showed a two-fold change. Based on earlier top-down approach
showing changes in 25 metabolite sets as determined by MSEA
(Chitturi et al., 2018), the present study focused on biochemical
consolidation. The 190 identified metabolites were subgrouped
based on their relationship to broader biochemical pathways e.g.,
oxidative energy and mitochondrial metabolism, glycolysis and
pentose phosphate pathway, fatty acid metabolism, amino acid
metabolism, neurotransmitters/neuromodulators (polyamines)
and one-carbon/folate metabolism. Remaining were subgrouped
as other metabolites (Supplementary Table S1). Biochemical
specificity and impact of TBI-induced changes were determined
in each subgroup.
Oxidative Energy and Mitochondrial
Metabolism
Eighteen metabolites that participate in the tricarboxylic acid
(TCA) cycle, electron transport chain and mitochondrial
metabolism were grouped together as oxidative energy and
mitochondrial metabolites. Comparison between sham and TBI
indicated significant change in 8 out of the 18 metabolites
(Figure 1A). Levels of citric acid and ADP were increased
in TBI animals compared to sham, whereas Oxaloacetic acid,
glycolic acid, glyoxylic acid, creatine, NAD and Oxoglutaric acid
decreased in TBI animals (Figure 1A). Multivariate analyses
using PLS-DA distinguished between sham and TBI classes
(Figures 1B,C) with a high accuracy as confirmed from the PLS-
DA model parameters (Accuracy = 1.0, R2 value = 0.97, Q2
value = 0.89) (Figure 1D).
Fatty Acid Metabolism After TBI
Comparison of fatty acid metabolites between sham and
TBI showed significant differences in 7 metabolites (36%)
out of 19-targeted metabolites (Figure 2A). Choline, an
important biochemical component of membrane phospholipids
decreased after TBI, suggesting decreased membrane turnover
and neuronal viability (Sanders and Zeisel, 2007). L-carnitine,
caprylic acid and 3-hydroxyhexadecanoic acid were also
decreased as a result of TBI. TBI also resulted in increased levels
of acylcarnitines including propionylcarnitine, hexanoylcarnitine
and L-acetylcarnitine (Figure 2A). Multivariate analyses using
PLS-DA (Figures 2B,C) showed distinct class separation between
sham and TBI with a good accuracy of the PLS-DA model
(Accuracy = 1.0, R2 value = 0.81, Q2 value = 0.72) (Figure 2D).
TBI-Induced Alterations in One
Carbon/Folate Metabolism
Comparison of metabolites that participate in one-carbon
metabolism between sham and TBI showed significant
differences in 5 metabolites (35%) out of the 14-targeted
metabolites (Figure 3A). Levels of S-adenosylmethionine
(SAMe) and glutathione increased after TBI, whereas levels
of pyridoxamine (vitamin B6), pyridoxine (vitamin B6) and
4-pyridoxic acid were significantly reduced (Figure 3A).
Multivariate analyses using PLS-DA (Figures 3B,C) showed
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FIGURE 1 | Oxidative energy metabolism at 72 h after TBI in the developing brain. (A) Volcano plot showing fold changes (FC) on x-axis and the negative logarithm
(base 10) of the FDR-adjusted P-values on y-axis. Black vertical and horizontal lines reflect the filtering criteria (FC = 1.0 and FDR based corrected P-value < 0.05).
Green or red dots represent metabolites that are significantly increased or decreased after TBI, respectively. 45% of the metabolites showed a significant change
between sham and TBI. Table on right shows metabolites that are significantly different as denoted by respective numbers in the figure on the left panel. (B,C)
PLS-DA analysis of the metabolite subgroup showing distinct class separation between sham and TBI. (D) PLS-DA model validation analysis and the predictive
accuracy indicate high accuracy of Q2 = 0.67, 0.80, and 0.89 for the three components, respectively.
distinct class separation between sham and TBI with a high
accuracy of the PLS-DA model (Accuracy = 1.0, R2 value = 0.96,
Q2 value = 0.82) (Figure 3D).
Glycolysis and Pentose Phosphate
Pathway
Citrate increased significantly after TBI with a high fold change.
However, citrate is a negative allosteric inhibitor of the glycolytic
enzyme phosphofructokinase, and its increase can slow down
glycolytic breakdown of glucose into pyruvate (Garland et al.,
1963). Therefore, we analyzed the subgroup containing 17
glycolysis and pentose phosphate pathway (PPP) metabolites.
30% of the metabolites showed significant changes in the
glycolysis and PPP subgroup (Figure 4A). TBI-induced changes
included increased levels of glucose 1-phosphate, glucose 6-
phosphate, glucosamine 6-phosphate and fructose 6-phosphate
(Figure 4A). Consistent with the inhibitory role of citrate on
glycolysis, levels of pyruvate, the end product of glycolysis,
decreased after TBI (Figure 4A). Multivariate analyses using
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FIGURE 2 | Fatty acid metabolism after TBI at 72 h after TBI in the developing brain. (A) Volcano plot showing FC on x-axis and FDR-adjusted P-values on y-axis.
Black vertical and horizontal lines reflect the filtering criteria (FC = 1.0 and FDR corrected P-value < 0.05). Green or red dots represent metabolites that are
significantly increased or decreased after TBI, respectively. 36% of the metabolites showed a significant change between sham and TBI. Table on right shows
metabolites that are significantly different as denoted by respective numbers in the figure on the left panel. (B,C) PLS-DA analysis of the fatty acid metabolite
subgroup showing distinct class separation between sham and TBI. (D) PLS-DA model validation analysis and the predictive accuracy indicate good accuracy of
Q2 = 0.72, 0.63 and 0.60 for the three components, respectively.
PLS-DA showed distinct class separation between sham and TBI
(Figures 4B,C), with a high accuracy of the PLS-DA model
(Accuracy = 0.93, R2 value = 0.93, Q2 value = 0.83), (Figure 4D).
Neurotransmitters Neuromodulators and
Polyamine Biosynthesis
Comparison between sham and TBI showed significant changes
in only 13% of the neurotransmitter metabolites. Levels of
adenosine and N-acetyl aspartic acid (NAA) and adenosine
decreased in TBI compared to sham (Figure 5A). However,
multivariate analyses using PLS-DA (Figures 5B,C) showed
distinct class separation between sham and TBI with a good
accuracy of the PLS-DA model (Accuracy = 1.0, R2 value = 0.95,
Q2 value = 0.86) (Figure 5D). The results indicate that
neurotransmitter perturbations after TBI was dominated by NAA
and adenosine changes with insignificant contribution from
other neurotransmitters.
TBI-Induced Amino Acid
Metabolic Perturbations
Amino acids and their related anabolic and catabolic products
were grouped together as related to amino acid metabolites.
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FIGURE 3 | One carbon/folate metabolism at 72 h after TBI in the developing brain. (A) Volcano plot showing FC on x-axis and FDR-adjusted P-values on y-axis.
Black vertical and horizontal lines reflect the filtering criteria (FC = 1.0 and FDR corrected P-value < 0.05). Green or red dots represent metabolites that are
significantly increased or decreased after TBI, respectively. 35% of the metabolites showed a significant change between sham and TBI. Table on right shows
metabolites that are significantly different as denoted by respective numbers in the figure on the left panel. (B,C) PLS-DA analysis of the carbon/folate metabolism
subgroup showing distinct class separation between sham and TBI. (D) PLS-DA model validation analysis and the predictive accuracy indicate high accuracy of
Q2 = 0.58, 0.66 and 0.82 for the three components, respectively.
TBI showed significant changes in 10% of the amino acid
metabolic products, when compared to sham. A unique aspect
of TBI impact on amino acid levels was that every significantly
changed amino acid showed only decreases (Figure 6A).
Multivariate analyses using PLS-DA (Figures 6B,C) showed
distinct class separation between sham and TBI with a good
accuracy of the PLS-DA model (Accuracy = 1.0, R2 value = 0.94,
Q2 value = 0.84) (Figure 6D).
TBI-Induced Alterations in
Other Metabolites
Approximately 56 metabolites were sub-grouped as other
metabolites, and none of the metabolites in this group were
significantly different between sham and TBI (Figure 7A).
Although multivariate analyses using PLS-DA (Figures 7B,C),
showed partial class separation between sham and TBI,
the accuracy of the PLS-DA model was weak from the
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FIGURE 4 | Glycolysis and pentose phosphate metabolism 72 h after TBI in the developing brain. (A) Volcano plot showing FC on x-axis and FDR-adjusted P-values
on y-axis. Black vertical and horizontal lines reflect the filtering criteria (FC = 1.0 and FDR corrected P-value < 0.05). Green or red dots represent metabolites that are
significantly increased or decreased after TBI, respectively. 30% of the metabolites showed a significant change between sham and TBI. Table on right shows
metabolites that are significantly different as denoted by respective numbers in the figure on the left panel. (B,C) PLS-DA analysis of the metabolite subgroup
showing distinct class separation between sham and TBI. (D) PLS-DA Model validation analysis and the predictive accuracy indicate high accuracy of Q2 = 0.71,
0.83 and 0.82 for the three components, respectively.
model validation (Accuracy = 0.86, R2 value = 0.83, Q2
value = 0.36) (Figure 7D).
DISCUSSION
The metabolite sets determined by MSEA related to specific
biochemical pathways affected by TBI in our earlier study
(Chitturi et al., 2018), was similar to the consolidated biochemical
profiles determined by the present study (Figures 1–6) with
oxidative energy metabolism being the most impacted (Figure 1).
A significant subgroup classified as other metabolites, which did
not belong to any critical biochemical pathway was observed to
have no significant effect after TBI (Figure 7). The following
discussion describes the specificity of TBI-induced changes in the
major biochemical pathways chronologically ranked based on the
neurochemical impact (Figure 8).
Energy crisis develops after TBI and known to be associated
with poor neurological outcomes (Ross and Soltesz, 2000; Prins
et al., 2013). A strong correlation between intense ipsilateral
metabolomic perturbations and neuronal cell death in the
current developmental rat model indicated the involvement of
multiple metabolic networks in addition to energy metabolism
(Chitturi et al., 2018). These broad TBI-induced metabolic
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FIGURE 5 | Neurotransmitters, neuromodulators and polyamine biosynthesis at 72 h after TBI in the developing brain. (A) Volcano plot showing FC on x-axis and
FDR-adjusted P-values on y-axis. Black vertical and horizontal lines reflect the filtering criteria (FC = 1.0 and FDR corrected P-value < 0.05). Green or red dots
represent metabolites that are significantly increased or decreased after TBI, respectively. 13% of the metabolites showed a significant change between sham and
TBI. Table on right shows metabolites that are significantly different as denoted by respective numbers in the figure on the left panel. (B,C) PLS-DA analysis of the
metabolite subgroup showing distinct class separation between sham and TBI. (D) PLS-DA Model validation analysis and the predictive accuracy indicate good
accuracy of Q2 = 0.41, 0.68 and 0.86 for the three components, respectively.
pathway disturbances led to poor ipsilateral neural viability
along with dysfunctional neuronal and neurovascular activities
into adolescence (Murugan et al., 2016; Parent et al., 2019).
Oxidative energy metabolic depression had the highest impact
on the subacute TBI pathophysiology with a Q2 = 0.89
(Figure 1). Amidst lowered energy metabolism and reduced
creatine levels, ATP generation is affected and accordingly
we observed increases in ADP levels after TBI (Figure 1).
A significant ipsilateral decrease in N-acetyl-aspartate (NAA)
levels in TBI when compared to sham (Figure 5A), indicated
mitochondrial and glycolytic dysfunction dominating the several
mechanisms enroute to neuronal death (Bates et al., 1996).
This emphasizes the central role of bioenergetic stress at the
apex, the intensity of which may predominantly steer the
subacute stage secondary neurodegenerative process after TBI.
The neurodegeneration reflected by NAA decrease is likely to be
in selective cellular populations as secondary neurodegeneration
is an ongoing process at 72 h after TBI and continues through
deeper cortical layers up to 7 days in the current rat model
(Lifshitz and Lisembee, 2011). Highly significant decrease in
Frontiers in Neuroscience | www.frontiersin.org 8 May 2019 | Volume 13 | Article 431
fnins-13-00431 May 2, 2019 Time: 17:43 # 9
Chitturi et al. Neurochemical Profile of Developmental TBI
FIGURE 6 | Amino acid metabolism 72 h after TBI in the developing brain. (A) Volcano plot showing FC on x-axis and FDR-adjusted P-values on y-axis. Black
vertical and horizontal lines reflect the filtering criteria (FC = 1.0 and FDR corrected P-value < 0.05). Green or red dots represent metabolites that are significantly
increased or decreased after TBI, respectively. 10% of the metabolites showed a significant change between sham and TBI. Table on right shows metabolites that
are significantly different as denoted by respective numbers in the figure on the left panel. (B,C) PLS-DA analysis of the amino acid metabolite subgroup showing
distinct class separation between sham and TBI. (D) PLS-DA model validation analysis and the predictive accuracy indicate high accuracy of Q2 = 0.36, 0.67 and
0.84 for the three components, respectively.
oxaloacetate (OAA) and increase in citric acid (Figure 1B),
along with significant changes in α-ketoglutarate (α-KG) levels
support an intensely reduced TCA cycle flux (Figure 1A).
Additionally, decreased NAD levels indicated impaired rate of
flow of NAD (an important co-factor) through the TCA cycle,
which conforms to the decreased α-KG and OAA and increased
citrate levels (Figure 1A).
Glycolysis is known to be affected after TBI due to insufficient
supply of NAD (Dusick et al., 2007; Jalloh et al., 2015). However,
PPP up regulation through glucose shunting toward PPP can
to a certain extent maintain NAD supply and help restore
TCA cycle metabolism (Bartnik et al., 2005). The specificity
of glycolytic changes showing decreases in pyruvate along
with accumulating glucose 1-phosphate, glucose 6-phosphate,
fructose 6-phosphate and glucosamine-6-phosphate (Figure 4A),
conformed a decreased glycolytic and increased oxidative phase
of PPP metabolism. High impact of the glycolytic and PPP
pathways to the TBI outcome observed by the PLS-DA model
accuracy (Figures 4B–D), suggest a PPP- based support to TCA
cycle based oxidative metabolism. Subacute stage PPP support
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FIGURE 7 | Other metabolites at 72 h after TBI in the developing brain. (A) Volcano plot showing FC on x-axis and FDR-adjusted P-values on y-axis. Black vertical
and horizontal lines reflect the filtering criteria (FC = 1.0 and FDR corrected P-value < 0.05). None of the metabolites in this group showed a significant change
between sham and TBI. (B,C) PLS-DA analysis of the other metabolites subgroup showed distinct classes between sham and TBI. (D) PLS-DA model validation
analysis and the predictive accuracy was significantly low Q2 = –0.15, 0.16 and 0.36 for the three components, respectively, indicating that TBI impact was
not significant.
may probably occur through restoration of the falling NAD
levels. Furthermore, a significant increase in reduced form of
glutathione (GSH) observed after TBI (Figure 3A) indicated
an up regulated PPP, which may sustain the increased need
for reducing equivalents in the subacute stage after TBI. GSH
is a tripeptide known to combat oxidative stress to maintain
normal cellular redox states (Winkler et al., 1986), formed by
the donation of electrons from NAD(P)H to oxidized glutathione
(GSSG) (Winkler et al., 1986), The decreased glycolytic and
TCA cycle metabolism along with increased PPP at P31-day
development indicate a prolonged bioenergetic stress, distinct
from the relatively lesser intensities observed in the immature
(P < 13) (Robertson et al., 2013) or adult TBI (Lee et al., 1999;
Sheline et al., 2000; Aquilani et al., 2005; Prins, 2017).
Although relatively less impacted (Q2 = 0.72) compared to
oxidative energy metabolism (Q2 = 0.89), fatty acid metabolism
showed significant changes in several metabolites in the subacute
stage after TBI. Choline, a principal lipid component of
membrane phospholipids was significantly decreased indicating
that repair of membranes and synaptic integrity may continue
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FIGURE 8 | Schematic of the different biochemical pathways affected by TBI and the ranking of developmental TBI impact on each of them.
to be affected during the subacute stages after TBI. L-carnitine,
an essential metabolite for transport of long-chain fatty acids
across the mitochondrial membrane (Jones et al., 2010), showed
significant decrease. Given the continued depression of oxidative
metabolism, this may lead to possible consequences of metabolic
encephalopathy, characterized by swollen astrocytes and enlarged
mitochondria (Kimura and Amemiya, 1990). Carnitine levels
are required for normal mitochondrial function, and have the
ability to repair mitochondrial function and improve functional
recovery after brain injury (Scafidi et al., 2010). Treatment
with L-carnitine and acetyl L-carnitine has shown significant
protection in the developing brain after a TBI (Ferreira and
McKenna, 2017), indicating the importance of maintaining
energy production through alternate means such as fatty acid
oxidation. Several acyl carnitines such as L-acetyl carnitine,
hexanoyl-carnitine, and propionyl-carnitine showed significant
increase after TBI (Figure 2). Accumulation of acyl carnitines
is an indicator of decreased mitochondrial TCA cycle flux
relative to fatty acid, glucose and/or amino acid oxidation
(Ribel-Madsen et al., 2016), indicative of severe mitochondrial
failure and ongoing neurodegeneration in selective populations
of neurons. Although accumulating acyl carnitines increase
fatty acid oxidation producing acetyl CoA, it consequently
increases oxygen demand in neurons, leading to increased
oxygen extraction fraction (OEF) and hence cellular hypoxia
(Schonfeld and Reiser, 2013). Mitochondrial populations are
particularly vulnerable in the brain with high concentrations
of acyl carnitines and regional hypoxia, known to worsen TBI
outcomes as observed in humans (Jeremitsky et al., 2003; Chi
et al., 2006; Spaite et al., 2017; Vella et al., 2017). Significant
decrease in the levels of 3-Hydroxyhexadecanoic acid (beta
oxidation product of saturated fatty acid; palmitic acid) indicated
increased oxidation of fatty acids during the subacute stage after
TBI (Figure 2A). Medium chain fatty acid, caprylic acid/octanoic
acid levels were also decreased after TBI. Caprylic acid in the
brain serves as a ketogenic compound where ketones from
caprylic acid generate necessary substrates for metabolically
perturbed mitochondria in order to sustain energy metabolism
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(Thaipisuttikul and Galvin, 2012). Further studies are required to
ascertain if the subacute ketogenic shift in brain metabolism after
TBI may be an intrinsic repair mechanism.
One carbon metabolism involving folate and methionine
metabolism, is required for SAMe synthesis, a major DNA
methylating agent. One carbon metabolism is also critical for
protein translation, sulfhydration, nucleotide, amino acid and
lipid head group metabolism (Locasale, 2013). TBI increased
SAM and glutathione levels (Figure 3A), impaired SAM
levels have been reported in chronic neurodegenerative disease
(Coppede, 2010). TBI also resulted in significant reduction in
two forms of vitamin B6- pyridoxine and pyridoxamine, and its
catabolic product 4-pyridoxic acid (Figure 3A). As B vitamins are
essential co-enzymes for TCA cycle, electron transport chain and
glycolysis (Kennedy, 2016), deficiency in any one form of vitamin
B may exacerbate the harmful effects of TBI emanating from
reduced brain energy metabolism. Vitamin B6 is also essential for
the catabolism and transamination of amino acids (Hwang et al.,
2007). A high impact of the one carbon/folate metabolic pathway
to TBI biochemical changes (Q2 value = 0.82; Figures 3B–D),
combined with therapeutic evidence of improved TBI outcomes
after administration of pyridoxine 30 min after a unilateral
TBI (Kuypers and Hoane, 2010), highlight the importance of
maintaining vitamin B6 metabolism after TBI.
Amino acid metabolism was significantly impacted after
TBI, (Q2 value = 0.84; Figures 6B–D). Specificity of changes
showed a decrease in methylacetoacetic acid, a beta-keto acid
and by product of isoleucine metabolism. Branched amino acids
(BCAAs) are both glucogenic (valine, isoleucine) and ketogenic
(leucine, isoleucine) and play an important role in energy
production and neurotransmitter synthesis. Phenylalanine
metabolism was significantly affected as observed by significant
decreases in phenyl pyruvic acid and hydrocinnamic acid
(Figure 6A). Alterations in phenylalanine metabolism results
in phenylketonuria, a detrimental condition to normal brain
development and cognitive maturation (Schuck et al., 2015).
Hence perturbed phenylalanine metabolism at the subacute stage
after TBI may affect ongoing developmental plasticity. Quinolic
acid, a metabolite of amino acid tryptophan also decreased
significantly after TBI. Tryptophan metabolism is critical for
normal brain function through the production of nicotinic acid,
a precursor of the important co-factor NAD, via metabolism of
quinolic acid (Moroni, 1999). NAD levels which significantly
decreased after TBI (Figure 1), maybe influenced by decreases
in the levels of quinolic acid. Hence the impact of amino
acid metabolic changes together with the impact of energetic
stress may provide a basis to interpret long-term changes in
pediatric TBI outcomes.
An important observation in the current study was the large
subgroup of remaining metabolites (56 out of a total of 190)
classified as “other metabolites” having no significant impact after
TBI (Q2 = 0.36). Specificity of changes also did not indicate any
significantly perturbed metabolites (Figure 7). A greater than 2-
fold increase in gluconic acid was, however, observed. While it
is known that gluconic acid is produced from glucose, further
studies are required to determine the exact significance of its
increase after TBI.
CONCLUSION
Differences between sham and TBI over the consolidated
biochemical pathways as summarized in the schematic
(Figure 8), indicated a broad TBI-induced biochemical shift in
the developing brain at the subacute stage of 72 h after injury.
Highest impact on brain bioenergetics with depressed TCA cycle
flux and a glycolytic shift toward PPP was observed, probably
as a response to maintain NAD supply and help restore TCA
cycle metabolism. Several other pathways such as fatty acid,
amino acid and neurotransmitter metabolism could be relatively
ranked. While the current study results represent the subacute
scenario in developmental TBI, it provides a consolidated
biochemical template to characterize a variety of experimental
TBI in animal models.
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